Studies on leptin and leptin receptor gene expression in myometrium and uterine myomas of GnRH analogue-treated women

European Journal of Gynaecological Oncology

Volumn 27, Issue 4, 2006, Pages 379-384

  Markowska, A ^a   Rucinski, M ^a   Drews, K ^a   Malendowicz, L K ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

GnRH analogue; Leptin; Leptin receptor; Uterine myoma

Indexed keywords

ESTROGEN; ESTRONE SULFATE; GONADORELIN DERIVATIVE; LEPTIN; LEPTIN RECEPTOR; PROGESTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HORMONE BLOOD LEVEL; HUMAN; MYOMETRIUM; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERUS MYOMA; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; CASE-CONTROL STUDIES; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GONADOTROPIN-RELEASING HORMONE; HUMANS; LEIOMYOMA; LEPTIN; MIDDLE AGED; MYOMA; MYOMETRIUM; RECEPTORS, CELL SURFACE; RECEPTORS, LEPTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UTERINE NEOPLASMS;

EID: 33748765562     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Andersen J.: "Growth factors and cytokines in uterine leiomyomas". Semin. Reprod. Endocrinol., 1996, 14, 269.
2. Senturk L.M., Sozen J., Gutierrez L., Arici A.: "Interleukin 8 production and interleukin 8 receptor expression in human myometrium and leiomyoma". Am. J. Obstet Gynecol., 2001, 184, 559.
3. Cramer S.F., Patel A.: "The frequency of uterine leiomyomas". Am. J. Clin. Pathol., 1990, 94, 435.
4. Tsibris J.C.M., Segars J., Coppola D., Mane S., Wilbanks G.D., Obrien W.F. et al.: "Insights from gene arrays on the developmental and growth regulation of uterine leiomyomata". Fertil. Steril., 2002, 78, 114.
5. Nowicki M., Adamkiewicz G., Bryc W., Kokot F.: "The influence of luteinizing hormone-releasing hormone analog on serum leptin and body composition in women with solitary uterine myoma". Am. J. Obstet. Gynecol., 2002, 186, 340.
6. Wizniter A., Marbach M., Hazum E., Insler V., Sharoni Y., Levy J.: "Gonadotropin-releasing specific binding sites in uterine leiomyomata". Biochem. Biophys. Res. Commun., 1988, 16, 152, 1326.
7. Colgan T.J., Pendergast S., LeBlanc M.: "The histopathology of uterine leiomyomas following treatment with gonadotropin-releasing hormone analogues". Hum. Pathol., 1993, 24, 1073.
8. Palomba S., Sammartino A., DiCarlo C., Affinito P., Zullo F., Nappi C.: "Effects of raloxifene treatment on uterine leiomyomas in postmenopausal women". Fertil. Steril., 2001, 76, 38.
9. Murphy A.A., Morales A.J., Kettel L.M., Yen S.S.C: "Regression of uterine leiomyomata to the antiprogesterone RU 486: dose-response effect". Fertil. Steril., 1995, 64, 187.
10. Shouzu M., Sumitani H., Segawa T., Yang H.J., Murakami K., Inoue M.: "Inhibition of in situ expression of aromatase P450 in leiomyoma of the uterus by leuprorelin acetate". J. Clin. Endocrinoi. Metab., 2001, 86, 5405.
11. Wilson E.A., Yang F., Rees D.: "Estradiol and progesterone binding in uterine leiomyomata and in normal uterine tissues". Obstet. Gynecol., 1980, 55, 20.
12. Puuka M.J., Kontula K.K., Kauppila A.J.I., Janne O.A., Vihko R.K.: "Estrogen receptor in human myoma tissue". Mol. Cell. Endocrinol., 1976, 6, 35.
13. Tamaya T., Motoyama T., Ohno Y. Ide N., Tsurusaki T., Okada H.: "Estradiol 17-b, progesterone, and 5-alpha-dihydrotestosterone receptors of uterine myometrium and myoma in the human subject". J. Steroid. Biochem., 1979, 10, 615.
14. Buttram V., Reiter R.C.: "Uterine leiomyomata: etiology, symptomatology, and management". Fertil Steril., 1981, 36, 433.
15. Van der Heijden O., Chiu H.C., Park T.C., Takahashi H., LiVolsi V.A., Risinger J.I. et al.: "Allelotype analysis of uterine leiomyoma: localization of a potential tumor suppressor gene to a 4-cM region of chromosome 7 q". Mol. Carcinog., 1998, 23, 243.
16. Vikhlyaeva E.M., Khodzhaeva Z.S., Fantschenko N.D.: "Familial predisposition to uterine leiomyomas". Int. J. Gynacol. Obstet., 1995, 51, 127.
17. Markowska A., Belloni A.S., Ruciński M., Parenti A.R., Nardelli G.B., Drews K. et al.: "Leptin and leptin receptor expression in the myometrium and uterine myomas: Is leptin involved in tumor development?". Int. J. Oncol., 2005, 27, 1505
18. Markowska A., Ruciński M., Drews K., Malendowicz L.K.: "Further studies on leptin receptor expression in myometrium and uterine myomas". Eur. J. Gynaecol. Oncol., 2005, 26, 517.
19. Deurenberg P., Weststrate J.A., Seidell J.C.: "Body mass index as a measure of body fatness: age and sex-specific prediction formulas". Br. J. Nutr., 1991, 65, 105.
20. Stewart E.A.: "Uterine fibroids". Lancet, 2001, 337, 293.
21. Rein M.S., Barbieri R.L., Friedman A.J.: "Progesterone: A critical role in pathogenesis uterine myomas". Am. J. Obstet Gynecol., 1995, 172, 14.
22. Rein M.S., Friedman A.J., Stuart J.M., MacLanghlin D.T.: "Fibroid and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate". Fertil. Steril., 1990, 53, 1018.
23. Friedman A.J., Harrison-Atlas D., Barbieri R.L., Benacerraf B., Gleason R., Schiff J.: "A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata". Fertil. Steril., 1989, 51, 251.
24. Wu M.H., Chuang P.C., Chen H.M., Lin C.C., Tsai S.J.: "Increased leptin expression in endometriosis cells is associated with endometrial stromal cell proliferation and leptin gene up-regulation". Mol. Hum. Reprod., 2002, 8, 456.
25. Sreenan J.J., Prayson R.A., Biscotti C.V., Thornton M.H., Easley K.A., Hart W.R.: "Histopathologic findings in 107 uterine leiomyomas treated with leuprolide acetate compared with 126 controls". Am. J. Surg. Pathol., 1996, 20, 427.
26. Nakamura Y., Yoshimura Y.: "Treatment of uterine leiomyomas in perimenopausal women with gonadotropine- releasing hormone agonists". Clin. Obstet. Gynecol. 1993, 36, 660.
27. Matalliotakis I.M., Koumantaki Y.G., Neonaki M.A., Goumenou A.G., Koumantakis G.E., Kuriakou D.S., Koumantakis E.E.: "Increase in serum leptin concentrations among women with endometriosis during danazol and leuprolide depot treatments". Am. J. Obstet Gynecol., 2000, 183, 58.
28. Nowicki M., Bryc W., Kokot F.: "Hormonal regulation of appetite and body mass in patients with advanced prostate cancer with combined androgen blockade". J. Endocrinol. Invest., 2001, 24, 31.
29. Krotkiewski M., Laudin K., Dahlgren E., Jonson P.O., Holm G.: "Effect of two modes of antiandrogen treatment on insulin sensivity and serum leptin in women with PCOS". Gynecol. Obstet. Invest., 2003, 55, 88.
30. Witchel S.F., Arslanian S., Lee P.A.: "Leptin concentrations in precocious puberty or untimely puberty with and without GnRH analogue therapy". J. Pediatr. Endocrinol. Metab., 1999, 12, 839.
31. Tommaselli G.A., Di Carlo C., Bifulco G., Di Spiezio Sardo A., Pellicano M., Nappi C.: "Serum leptin levels in patients with premenopausal syndrome treated with GnRH analogues alone and association with tibolone". Clin. Endocrinol., 2003, 59, 716.
32. Mix H., Widjaja A., Jandl O., Cornberg M., Kaul A., Goke M. et al.: "Expression of leptin and leptin receptor isoforms in the human stomach". Gut, 2000, 47, 481.
33. Lima-Couy I., Cervero A., Bonilla-Musoles F., Pellicer A., Simon C.: "Endometrial leptin and leptin receptor expression in women with severe/moderate endometriosis". Mol. Human Reprod., 2004, 10, 777.
34. Vigano P., Somigliana E., Matrone R., Dubini A., Barron C., Vignali M., Di Blasio A.M.: "Serum leptin concentrations in endometriosis". J. Clin. Endocrinol. Metab., 2002, 87, 1085.
35. Matarese G., Alviggi C., Sanna V., Howard J.K., Lord G.M., Carravetta C. et al.: "Increased leptin levels in serum and peritoneal fluid of patients with pelvic endometriosis". J. Clin. Endocrinol. Metab., 2000, 85, 2483.
36. Ercolani L., Florence B., Denaro M., Alexander M.: "Isolation and complete sequence of a functional human glyceraldehydes-3-phosphate dehydrogenase gene". J. Biol. Chem., 1988, 263, 15335.
37. Brossait P., Keilholz U., Scheibenbongen C., Mohler T., Willhauck M., Hunstein W., et al.: "Detection of residual tumor cells in patients with malignant melanoma responding to immunotherapy". J. Immunother., 1994, 15, 38.
38. Isse N., Ogawa Y., Tamura N., Masuzaki H., Mori K., Okazaki T., et al.: "Structural organization and chromosomal assignment of the human obese gene". J. Biol. Chem., 1995, 46, 27728.
39. Chung W.K., Power-Kehoe L., Chua M., Lee R., Leibel R.L.: "Genomic structure of the human OB receptor and identification of two novel intronic microsatellites". Genome Res., 1996, 12, 1192.
40. Bennet B.D., Solar G.P., Yuan J.Q., Mathias J., Thomas Gr., Matthews W.: "A role of leptin and its cognate receptor in hematopoesis". Current Biology, 1996, 6, 1170.
41. Cioffi J.A., Shafer A.W., Zupancic T.J., Smith-Gbur J., Mikhail A., Platika D. et al.: "Novel B219/OB. Receptor isoforms: Possible role of leptin in hematopoesis and reproduction". Nature Med., 1996, 2, 585.